Literature DB >> 26816944

Placenta Percreta Presenting with Delayed Haematuria.

Vinayak Gorakhanath Wagaskar1, Sudarshan Omprakash Daga1, Sujata Kiran Patwardhan2.   

Abstract

Placenta percreta presents as life threatening complications with bladder invasion. A condition of placenta invading urinary bladder presented with differential diagnosis of gestational trophoblastic neoplasia on imaging and responded to chemotherapy. A 35-year-old primi-gravida presented at term with per vaginal bleeding. During caesarian section placental mass totally invading uterine myometrium was found. She was given single dose of Methotrexate. After 2 months she presented with gross haematuria with clot retention two times. Her MRI was suggestive of gestational trophoblastic neoplasia of size 19 X 10 X 13cm. Her beta-Human Chorionic Gonadotropin levels were 691.23 mIU/ml. She was given total four doses of methotrexate. At present size of mass was 1.6 X1.3X 1.1cm. Her beta Human Chorionic Gonadotropin level dropped down to 2mIU/ml. Patient was not willing for further intervention or for follow up.

Entities:  

Keywords:  Bladder invasion; Hysterectomy; Mass methotrexate; Placenta percreta

Year:  2015        PMID: 26816944      PMCID: PMC4717779          DOI: 10.7860/JCDR/2015/16411.6935

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Conservative treatment of placenta increta with methotrexate.

Authors:  R Crespo; M Lapresta; B Madani
Journal:  Int J Gynaecol Obstet       Date:  2005-08-29       Impact factor: 3.561

2.  Premature rupture of membranes, placenta increta, and hysterectomy in a pregnancy following endometrial ablation.

Authors:  B D Hamar; E F Wolff; P H Kodaman; I Marcovici
Journal:  J Perinatol       Date:  2006-02       Impact factor: 2.521

3.  Conservative management of placenta previa percreta by leaving placental tissue in situ with arterial ligation and adjuvant methotrexate therapy.

Authors:  Teksin Cırpan; Cem Yaşar Sanhal; Sait Yücebilgin; Serdar Ozşener
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-06-01

4.  Abnormal placentation: twenty-year analysis.

Authors:  Serena Wu; Masha Kocherginsky; Judith U Hibbard
Journal:  Am J Obstet Gynecol       Date:  2005-05       Impact factor: 8.661

5.  Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial.

Authors:  Gaylene Pron; Eva Mocarski; John Bennett; George Vilos; Andrew Common; Leslie Vanderburgh
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

6.  Hematuria: an unusual presentation of placenta percreta.

Authors:  Pooja Gupta; Yashodhara Pradeep; Apul Goel; Renu Singh
Journal:  Urology       Date:  2012-06-27       Impact factor: 2.649

7.  ACOG committee opinion. Placenta accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  2002-04       Impact factor: 3.561

8.  Placenta accreta: an association with fibroids and Asherman syndrome.

Authors:  Amal Al-Serehi; Anna Mhoyan; Michelle Brown; Kurt Benirschke; Andrew Hull; Dolores H Pretorius
Journal:  J Ultrasound Med       Date:  2008-11       Impact factor: 2.153

9.  Placenta percreta and the urologist.

Authors:  Ramdev Konijeti; Jacob Rajfer; Asghar Askari
Journal:  Rev Urol       Date:  2009
  9 in total
  1 in total

1.  Placenta percreta with bladder invasion: The armamentarium available in its management.

Authors:  Neeraja Tillu; Abhishek Savalia; Sujata Patwardhan; Bhushan Patil
Journal:  Urol Ann       Date:  2019 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.